Researcher Next
Create account
← Back to directory

Pamela Salman

Researcher Next ID · RN-010551

Researcher · Medicine

Fundación Arturo López Pérez

, Chile

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
34
Citation count
15,746
H-index
18
i10-index
22

Research interests

Medicine
Gastric Cancer Management and Outcomes
Renal cell carcinoma treatment
Cancer Immunotherapy and Biomarkers
Colorectal Cancer Treatments and Studies
Lung Cancer Treatments and Mutations

Publications

  • First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

    The Lancet · 2021 · 10.1016/s0140-6736(21)00797-2

  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    The Lancet Oncology · 2019 · 10.1016/s1470-2045(19)30413-9

  • Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1712126

  • Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

    The Lancet Oncology · 2013 · 10.1016/s1470-2045(13)70102-5

  • Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

    Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.23.9764

Current projects

    No projects listed.